Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/NH/Manchester
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Manchester, NH

Studies commonly pay $75 to $4,500 per completed study

88 clinical trials are currently recruiting participants within 30 miles of Manchester. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

88studies recruiting
9+research centers nearby
6condition categories
Live from the NIH registry

Studies recruiting near Manchester right now

Top 25 of 88 recruiting studies, sorted by proximity — each links to its official registry page

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Phase 2 Interventional 40 participants sought
Ohio State University-Telemedicine — Concord, New Hampshire (16.1 mi) · Sponsor: Sameek Roychowdhury
See eligibility & contact on ClinicalTrials.gov (NCT06906562)

Randomized Single Center Study to Evaluate Tolerability, Symptoms, and Visual Functional Outcomes With the Use of OTC Lubricating Eye Drops in Subjects With Dry Eye Disease

Dry Eye Disease (DED) Phase 4 Interventional 60 participants sought
Andover Eye Associates — Andover, Massachusetts (27.4 mi) · Sponsor: Andover Research Eye Institute
See eligibility & contact on ClinicalTrials.gov (NCT07676084)

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Lymphoma, Non-Hodgkin, Multiple Myeloma Phase 2 Interventional 4,200 participants sought
Solinsky Center for Cancer Care — Manchester, New Hampshire (0.9 mi) · Sponsor: American Society of Clinical Oncology
See eligibility & contact on ClinicalTrials.gov (NCT02693535)

Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD

Age-Related Macular Degeneration, Geographic Atrophy N/A Interventional 125 participants sought
Tallman Eye Associates — Lawrence, Massachusetts (23.9 mi) · Sponsor: VisionCare, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT05438732)

ALPCO Calprotectin CLIA Assay - Measurement of Calprotectin Levels in Human Stool

Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis), Inflammatory Bowel Syndrome N/A Observational 220 participants sought
ALPCO — Salem, New Hampshire (18.3 mi) · Sponsor: American Laboratory Products Company
See eligibility & contact on ClinicalTrials.gov (NCT06810518)

A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants

Hypothyroidism Phase 2, Phase 3 Interventional 2,800 participants sought
Southern New Hampshire Diabetes and Endocrinology /ID# 257841 — Nashua, New Hampshire (15.2 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT06345339)

A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain

Osteoarthritis, Knee, Diabetic Neuropathic Pain Phase 2 Interventional 10,000 participants sought
ActivMed Practices and Research — Methuen, Massachusetts (22.0 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT05986292)

Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients

Non Small Cell Lung Cancer, Epidermal Growth Factor Receptor Gene Mutation N/A Observational 538 participants sought
Lowell General Hosptial — Lowell, Massachusetts (25.1 mi) · Sponsor: PrECOG, LLC.
See eligibility & contact on ClinicalTrials.gov (NCT06538038)

Precision Ventilation vs Standard Care for Acute Respiratory Distress Syndrome

Acute Respiratory Distress Syndrome, Respiratory Failure Phase 3 Interventional 1,100 participants sought
Lowell General Hospital — Lowell, Massachusetts (25.1 mi) · Sponsor: Beth Israel Deaconess Medical Center
See eligibility & contact on ClinicalTrials.gov (NCT06066502)

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Stage I Breast Cancer Phase 3 Interventional 1,670 participants sought
Solinsky Center for Cancer Care — Manchester, New Hampshire (0.9 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT04852887)

Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol

Binge-Eating Disorder Phase 3 Interventional 450 participants sought
Clinical Research Site — Methuen, Massachusetts (22.0 mi) · Sponsor: Axsome Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06413433)

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 Phase 3 Interventional 1,100 participants sought
Dartmouth Cancer Center - Manchester/ DCC Manchester — Manchester, New Hampshire (0.9 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06632327)

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma Phase 3 Interventional 1,273 participants sought
Elliot Hospital — Manchester, New Hampshire (0.9 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03678025)

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Breast Cancer Phase 3 Interventional 4,220 participants sought
Dana Farber Cancer Institute - Merrimack Valley — Methuen, Massachusetts (22.0 mi) · Sponsor: Stemline Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06492616)

A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA

Growth Hormone Deficiency N/A Observational 900 participants sought
Ascendis Investigational Site — Manchester, New Hampshire (0.9 mi) · Sponsor: Ascendis Pharma Endocrinology Division A/S
See eligibility & contact on ClinicalTrials.gov (NCT05820672)

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Phase 2 Interventional 56 participants sought
Solinsky Center for Cancer Care — Manchester, New Hampshire (0.9 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT06031688)

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Cardiovascular Disease Phase 3 Interventional 15,100 participants sought
Research Site — Haverhill, Massachusetts (23.5 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT07000357)

An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)

Breast Cancer, Early Breast Cancer Phase 3 Interventional 5,500 participants sought
Research Site — Manchester, New Hampshire (0.9 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT05952557)

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Diabetes Mellitus, Type 2, Hypertension Phase 3 Interventional 11,800 participants sought
ActivMed Practices & Research — Methuen, Massachusetts (22.0 mi) · Sponsor: Boehringer Ingelheim
See eligibility & contact on ClinicalTrials.gov (NCT07064473)

S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive N/A Interventional 739 participants sought
Elliot Hospital — Manchester, New Hampshire (0.9 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03723928)
Actively enrolling

Studies you may be able to join near Manchester

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Manchester

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Advanced Regenerative Manufacturing Institute (ARMI) / BioFabUSA

★ 3.2
Technology Center, University Center, 400 N Commercial St, Manchester, NH 03101
(603) 666-3905
"I'm just curious if any regular patients have had a new kidney from them, yet??? Anybody?? Because people NEED kidneys the most so what's the prognos…"
— A Google User, 2★

Dartmouth Cancer Center Manchester | Head & Neck Cancer Program

87 McGregor St, Manchester, NH 03102
(603) 629-1828

Tellica Imaging - Manchester

★ 5.0
1100 Bicentennial Dr Unit B-3, Manchester, NH 03104
(603) 782-4303
"Cat scan done by Lynn and MRI done by Wayne, several days apart. Both terrically well done."
— John Scheide, 5★

Clinical Trials of New England

1234 Hyde Park Ave #205, Hyde Park, MA 02136

ActivMed Practices & Research, LLC

★ 4.6
421 Merrimack St #203, Methuen, MA 01844
(978) 655-7155
"This office is great. I have volunteered for a few studies at other labs, but I like this the one the best so far."
— Robert Grant, 5★

Innovative Psychiatry Center

★ 4.8 (75 reviews)
258 S River Rd, Bedford, NH 03110
(603) 758-3192
"My psychiatrist is very helpful and easy to talk to."
— T W, 5★

BMC Clinical Research Unit

850 Harrison Ave 6th floor, Boston, MA 02118
(617) 638-8855

Boston Clinical Trials

★ 4.4
26 Cummins Hwy, Boston, MA 02131
(617) 477-4868
"Very well organized and telephone health checks were very helpful in getting a good sample collection. Would do this again if offered."
— Mary Wolfe, 5★

St. Joseph Hospital Family Medicine & Specialty Services - Merrimack

★ 4.8
4 Dobson Way, Merrimack, NH 03054
(603) 424-4181
"I’ve been a patient of Cathy ODonnell for over 20years. She is easy to talk to and very thorough and knowledgeable about women’s health."
— Nina Raymond, 5★

Clinical trials in Manchester: what's recruiting

The Manchester area currently has 88 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Manchester, the most active research areas are:

  • Cancer & Oncology12 studies
  • Immune & Skin3 studies
  • Diabetes & Metabolism3 studies
  • Brain & Mental Health2 studies
  • Heart & Vascular2 studies

Every listing shows the study phase, the recruiting site and its distance from Manchester, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Manchester

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Manchester participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Are clinical trials in Manchester safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Manchester, NH?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
What is the difference between a research center and a hospital study in Manchester?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Manchester?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Manchester.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Manchester typically complete one or two studies per year.

Paid clinical trials near Manchester

Other metros within reach

Nashua, NH262 Boston, MA2,960 Worcester, MA273 Providence, RI558 Portland, ME171 Springfield, MA317 New Bedford, MA519 Norwich, CT123

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Manchester Bladder Issues Due To Spinal Cord Injury in Manchester All conditions

More of NH

Nashua262

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts